Radiation Therapy (Human)(1 expert discussions analyzed)

Radiation therapy uses ionizing radiation (X-rays, gamma rays, or particle beams such as protons) to treat disease. The dominant clinical use is cancer treatment: highly focused, computer-guided delivery (proton therapy, stereotactic body radiation therapy, image-guided radiation therapy) treats solid tumors with millimeter precision. A separate, distinct application is low-dose radiation for chronic inflammatory conditions like osteoarthritis, plantar fasciitis, and tendonitis — used for decades in parts of Europe, particularly Germany. The cancer-treatment and low-dose-inflammatory applications use fundamentally different doses and mechanisms; conflating them distorts both treatment decisions and patient anxiety.

Modern oncologic radiation has changed dramatically over the past two decades. Computer-guided delivery with millimeter precision is fundamentally different from older external-beam treatments. For some localized cancers (particularly prostate and certain breast cancers), modern precision radiation may achieve outcomes comparable to surgery for selected patients and cancer types, with substantially lower side-effect burden. The choice between radiation and surgery depends on patient factors, tumor characteristics, and trade-offs — not on which specialist the patient happens to see first. Some surgical oncologists favor surgery as more definitive; some radiation oncologists favor radiation as less invasive.

Low-dose radiation for chronic inflammatory conditions has been a standard option in Germany and parts of Central Europe for decades, used for osteoarthritis, plantar fasciitis, tendonitis, and similar conditions. The doses are far lower than cancer doses and are thought to operate through a hormetic response (the body's anti-inflammatory adaptation to low-energy exposure) rather than through cell killing. US, UK, Canadian, and Australian guidelines have not broadly adopted this practice; high-quality randomized evidence remains limited compared with many standard orthopedic and rheumatologic treatments. The application is real and worth knowing about if standard therapies have failed, but should not be presented as established care outside the specific European contexts where it is established.

Ionizing radiation (X-rays, gamma rays, alpha particles) deposits energy that can damage DNA, with cumulative risk over a lifetime. Non-ionizing radiation (visible light, radio waves, microwaves) generally does not. Patient anxiety about 'radiation' often conflates these very different exposures. MRI uses no ionizing radiation, while CT scans deliver cumulative ionizing dose; this distinction matters when evaluating cumulative imaging exposure across a lifetime. Knowing which type of radiation a specific test or treatment involves is the first practical question worth asking.

This page is built on a single expert source: Dr. Sanjay Mehta on the Peter Attia Drive podcast. Dr. Mehta is President of Century Cancer Centers, a commercial radiation oncology practice in Houston. His enthusiasm for both oncologic precision radiation and low-dose-inflammatory radiation applications aligns with his commercial interest. This does not invalidate the underlying clinical points — modern radiation is genuinely precision-improved, and low-dose radiation for arthritis is a real European tradition — but specific treatment-promotion claims should be cross-checked with independent academic radiation oncology sources for high-stakes decisions. Future versions of this page should incorporate sources from academic medical centers (Memorial Sloan Kettering, MD Anderson, the European cooperative groups) and patient-organization perspectives.